This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Results
In the pre-pathway group, 218 patients (47.9%) received a cholecystectomy on initial hospitalisation, compared with 87 (77.7%) in the post-pathway group (p<0.0001). There was no difference in operative mortality and in operative complications between the two groups.
The mean length of stay for the initial hospitalisation was 5.4 days (SD 4.3) in pre-pathway patients compared with 4.4 days (SD 3.0) in post-pathway patients (p=0.010). The total mean overall length of stay decreased from 7.1 days before to 4.5 days after implementation of the pathway (p<0.0001).
In the pre-pathway group, 150 patients (33.0%) had at least one hospital readmission for gallstone problems or operative complications, compared with 11 patients (9.8%) in the post-pathway group (p<0.0001).
Total mean charges per patient were $27,981 (SD 21,736) in the pre-pathway group, compared with $26,888 (SD 15,044) in the post-pathway group (p=0.530).
Authors' conclusions
The authors concluded that the implementation of a multidisciplinary critical pathway improved cholecystectomy rates on initial hospitalisation and lowered the costs by shortening the length of stay and reducing readmissions.
CRD commentary

Interventions:
The interventions were reported clearly and in detail.
Effectiveness/benefits:
The clinical and effectiveness data were from a before-and-after study undertaken in a tertiary hospital. The authors determined that the two patient groups were similar in their baseline characteristics, but this study design is prone to biases. For example, patients could have differed systematically in unobserved characteristics; or external factors, such as changes in hospital management, could have produced differences between the two groups. The patients in the prepathway group were followed-up for six months, but not all of the patients in the post-pathway group were; some of these patients only had one month of follow-up. Patients in the post-pathway group could have had lower readmissions and complications, and shorter hospital stays simply because they were followed-up for a shorter period.
Costs:
The perspective was not explicitly reported, but it was that of the hospital. For this perspective, it appears that all the relevant costs were included. The sources for the cost information and resource use were reported. The authors found a non-significant difference in costs between the two groups. As with the effectiveness data, this could have been due to patients in the post-pathway group being followed-up for less time than those in the pre-pathway group. The time horizon and currency were reported, but the price year was not and this will hamper future inflationary exercises.
Analysis and results:
